Pallas Capital Advisors LLC Purchases 6,384 Shares of Molina Healthcare, Inc $MOH

Pallas Capital Advisors LLC increased its holdings in shares of Molina Healthcare, Inc (NYSE:MOH) by 105.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,431 shares of the company’s stock after acquiring an additional 6,384 shares during the quarter. Pallas Capital Advisors LLC’s holdings in Molina Healthcare were worth $2,379,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MOH. First Horizon Advisors Inc. grew its stake in shares of Molina Healthcare by 2,140.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock worth $33,000 after acquiring an additional 107 shares during the period. CYBER HORNET ETFs LLC bought a new position in Molina Healthcare during the second quarter worth about $45,000. MUFG Securities EMEA plc purchased a new position in shares of Molina Healthcare in the second quarter worth about $48,000. Zions Bancorporation National Association UT increased its stake in shares of Molina Healthcare by 121.8% in the second quarter. Zions Bancorporation National Association UT now owns 193 shares of the company’s stock worth $57,000 after purchasing an additional 106 shares in the last quarter. Finally, Bogart Wealth LLC bought a new stake in shares of Molina Healthcare in the third quarter valued at approximately $39,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Trading Up 6.7%

Molina Healthcare stock opened at $135.20 on Tuesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.69 and a current ratio of 1.69. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $359.97. The stock has a market cap of $6.96 billion, a P/E ratio of 15.79 and a beta of 0.49. The firm’s fifty day moving average price is $170.68 and its 200-day moving average price is $169.32.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). The business had revenue of $11.38 billion for the quarter, compared to analysts’ expectations of $10.90 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.Molina Healthcare’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.05 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities research analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the transaction, the director directly owned 11,352 shares in the company, valued at approximately $1,623,563.04. This represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.26% of the company’s stock.

Wall Street Analysts Forecast Growth

MOH has been the subject of several analyst reports. TD Cowen cut their price objective on shares of Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a report on Monday, February 9th. Mizuho set a $220.00 target price on Molina Healthcare in a research report on Friday, January 9th. Barclays cut their price target on Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating for the company in a report on Tuesday, February 10th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a research note on Thursday, January 22nd. Finally, UBS Group reissued a “neutral” rating and set a $145.00 price objective on shares of Molina Healthcare in a report on Monday, February 9th. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $164.79.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.